Monash University

Embargoed and Restricted Access

Reason: Under embargo until July 2020. After this date a copy can be supplied under Section 51 (2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library

Development of therapeutic vaccines against ovarian cancer

posted on 2017-07-31, 00:01 authored by QIAN GAO
Ovarian cancer (OC) is a gynecological malignancy with high morbidity and mortality. There is an urgent need for other therapeutic approaches for ovarian cancer. In this study, we explored a promising protein antigen Sp17 for OC vaccine development. We investigated the role of Sp17 in tumorigenicity and chemoresistance and mapped the T cell and B cell epitopes within this protein to support the Sp17 peptide based vaccine development. We also investigated the vaccine formulation Sp17 peptides adjuvanted by nanoparticles. We found many new properties of immune responses can be induced by the nanovaccine formulation.


Principal supervisor

Magdalena Plebanski

Year of Award


Department, School or Centre

Central Clinical School

Campus location



Doctor of Philosophy

Degree Type



Faculty of Medicine Nursing and Health Sciences

Usage metrics

    Faculty of Medicine, Nursing and Health Sciences Theses